Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$11,730,335
-$8,349 QoQ
Shares Held
74,849
-2.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#156
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Capital Management, Inc. holds $39,718,306 across 10 Drug Manufacturers - General names. NVS ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
74,849 | $11,730,335 | |
| 2 | JNJ |
Johnson & Johnson
|
42,818 | $10,874,487 | |
| 3 | LLY |
ELI LILLY & Co
|
8,143 | $9,766,959 | |
| 4 | ABBV |
AbbVie Inc.
|
10,042 | $2,526,968 | |
| 5 | PFE |
Pfizer Inc
|
67,037 | $1,614,250 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
14,350 | $826,847 | |
| 7 | AMGN |
Amgen Inc
|
2,224 | $805,354 | |
| 8 | MRK |
Merck & Co., Inc.
|
5,967 | $766,759 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,730,335 | 74,849 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $11,738,684 | 76,849 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $10,562,634 | 76,613 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $9,824,851 | 76,613 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $9,349,595 | 77,263 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $8,796,106 | 78,903 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $7,678,050 | 78,903 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $9,210,571 | 80,078 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $8,525,103 | 80,078 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $7,745,944 | 80,078 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $8,085,475 | 80,078 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $8,163,875 | 80,148 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $8,087,734 | 80,148 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $7,373,616 | 80,148 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $7,304,411 | 80,516 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $6,120,021 | 80,516 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $6,932,812 | 82,016 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $7,196,904 | 82,016 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,173,939 | 82,016 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $6,707,268 | 82,016 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $7,483,139 | 82,016 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,011,582 | 82,026 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $7,745,715 | 82,026 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $7,274,464 | 83,653 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $7,306,253 | 83,653 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $6,897,189 | 83,653 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||